Resting state alpha frequency is associated with menstrual cycle phase, estradiol and use of oral contraceptives  by Brötzner, Christina P. et al.
Available online at www.sciencedirect.comwww.elsevier.com/locate/brainres
b r a i n r e s e a r c h 1 5 7 7 ( 2 0 1 4 ) 3 6 – 4 4http://dx.doi.org/10.101
0006-8993 & 2014 The A
(http://creativecommon
nCorresponding a
Fax: þ43 662 8044 56
E-mail address: hResearch ReportResting state alpha frequency is associated with
menstrual cycle phase, estradiol and use
of oral contraceptivesChristina P. Bro¨tznera,b, Wolfgang Klimeschb,c, Michael Doppelmayrc,d,
Andrea Zaunerb, Hubert H. Kerschbauma,c,n
aDepartment of Cell Biology, University of Salzburg, Salzburg, Austria
bDepartment of Physiological Psychology, University of Salzburg, Salzburg, Austria
cCenter for Neurocognitive, Research, University of Salzburg, Salzburg, Austria
dDepartment of Sportscience, University of Mainz, Mainz, Germanya r t i c l e i n f o
Article history:Accepted 27 June 2014
Ongoing intrinsic brain activity in resting, but awake humans is dominated by alpha
oscillations. In human, individual alpha frequency (IAF) is associated with cognitiveAvailable online 7 July 2014
Keywords:
Estradiol
Individual alpha frequency
Center frequency
Oral contraceptive6/j.brainres.2014.06.034
uthors. Published by Elsevie
s.org/licenses/by-nc-nd/3.0/)
uthor at: Department of
98.
ubert.kerschbaum@sbg.aa b s t r a c t
performance. Noticeable, performance in cognitive and emotional tasks in women is
associated with menstrual cycle phase and sex hormone levels, respectively. In the present
study, we correlated frequency of alpha oscillation in resting women with menstrual cycle
phase, sex hormone level, or use of oral contraceptives. Electroencephalogram (EEG) was
recorded from 57 women (aged 24.0773.67 years) having a natural menstrual cycle as well
as from 57 women (aged 22.3772.20 years) using oral contraceptives while they sat in an
armchair with eyes closed. Alpha frequency was related to the menstrual cycle phase.
Luteal women showed highest and late follicular women showed lowest IAF or center
frequency. Furthermore, IAF as well as center frequency correlated negatively with
endogenous estradiol level, but did not reveal an association with endogenous progester-
one. Women using oral contraceptives showed an alpha frequency similar to women in the
early follicular phase. We suggest that endogenous estradiol modulate resting alpha
frequency.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).r B.V. This is an open access article under the CC BY-NC-ND license
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Cell Biology, University of Salzburg, Hellbrunnerstr. 34, 5020 Salzburg, Austria.
c.at (H.H. Kerschbaum).1. Introduction
Fluctuations of estradiol and progesterone during natural
menstrual cycles are fundamental in synchronizing cellularactivities. In the periphery, sex hormone oscillations synchro-
nize differentiation of ovarian follicles with epithelial matura-
tion in uterus. In the central nervous system, changes in sex
hormones are captured in changes in neuronal architecture,
b r a i n r e s e a r c h 1 5 7 7 ( 2 0 1 4 ) 3 6 – 4 4 37excitability, and cognitive processes (McEwen et al., 2012).
In women, volume increase in areas of the temporal lobe
correlates with elevated estradiol levels (Protopopescu et al.,
2008, Pletzer et al., 2010, De Bondt et al., 2013). Estradiol and
progesterone are potent neuromodulators. In general, estradiol
increases and progesterone decreases neuronal excitability
(Finocchi, Ferrari, 2011). Furthermore, estradiol or menstrual
cycle phases having elevated levels of estradiol correlate
positively with performance in verbal memory tasks, working
memory, paired-associate learning, but negatively with
performance in spatial tasks (Hampson and Kimura 1992;
Phillips and Sherwin, 1992, Hampson 1990, Hausmann et al.,
2000, Rosenberg and Park, 2002, Maki et al. 2002).
Ovarian steroid hormone ﬂuctuations correlate with
changes in energy balance in reproductively fertile women.
In comparison to the follicular phase, energy expenditure and
food intake is increased in the luteal phase (Buffenstein et al.,
1995). Nutritional and endocrinological studies on rodents,
non-human primates and humans revealed that estradiol
has an inhibitory impact on food intake (Buffenstein et al.,
1995). Although the weight of the brain is 2% of the total body
weight, it consumes about 20% of the energy. Task processing
increases energy consumption only by about 5% (Raichle,
2010). Critically, more than 90% of cortical neurons are
glutamatergic (Braitenberg, Schüz, 1991), and the great major-
ity of energy in the human brain is presumably consumed by
excitatory glutamatergic synapses (Attwell and Laughlin,
2001, Raichle, 2010). Synchronized oscillatory activity mon-
itored by the EEG during event related potentials or sponta-
neous, intrinsic activity is related to synaptic activity (Buzsáki
et al., 2012). Interestingly, Hans Berger, who described alpha
oscillations for the ﬁrst time, concluded already in 1929
that “… mental work … adds only a small increment to the
cortical work which is going on continuously …” (Berger,
1929, Raichle, 2010). Considering that the majority of energy
is consumed in the resting – but awake – brain at glutama-
tergic synapses, EEG signals represent synchronous activity
of glutamatergic synapses, and ﬂuctuations in ovarian steroid
hormones determine energy expenditure and food intake in
women, we assumed that the frequency of ongoing alpha
oscillations is related to the level of estradiol or progesterone.
Women using oral contraceptives differ in their response
to speciﬁc tasks as well as in their resting state from women
having a natural menstrual cycle. Compared to women with a
natural menstrual cycle, women using oral contraceptives
show a stronger BOLD response to faces in the right fusiform
face area (Marecková et al., 2014), but a smaller BOLD
response to erotic stimuli in the left precentral gyrus (Abler
et al., 2013). In a numerical task, women using oral contra-
ceptives have a BOLD response similar to men (Pletzer et al.,
2014). Critically, Petersen and colleagues describe that oral
contraceptives as well as endogenous sex hormones are
associated with a decrease in connectivity in the resting state
network (Petersen et al., 2014). Furthermore, recent voxel-
based morphometric studies revealed some areas in the
frontal and temporal lobe that were larger in women using
oral contraceptives compared to women having a natural
menstrual cycle (Pletzer et al., 2010, De Bondt et al., 2013).
Alpha oscillations (8–12 Hz) are the dominant frequency
band in the human EEG (Klimesch, 1997). Typically,amplitude of the alpha rhythm is largest with the eyes closed
and attenuates when eyes are opened. Accordingly, this
alpha desynchronization was interpreted as suppression of
sensory input or event-related desynchronization. However,
more recently, alpha oscillations are seen as functional as
well as physiological inhibition (Klimesch, 1997, 1999).
In addition Anokhin and Vogel (1996) pointed out that alpha
frequency is positive correlated with intelligence, a ﬁnding
that has been replicated recently correlating individual alpha
frequency and general intelligence g (Grandy et al. 2013).
The aims of the present study were to evaluate the
frequency of alpha oscillations in resting state conditions
(1) across the menstrual cycle, (2) in relation to endogenous
estradiol or progesterone, and (3) in the active and inactive
phase of oral contraceptive use.2. Results
2.1. Alpha oscillations in resting state conditions have a
higher frequency in luteal compared to follicular women
To evaluate whether frequency of ongoing EEG was men-
strual cycle-dependent we (1) calculated IAF and center
frequency as detailed in Experimental procedures and (2) com-
pared IAF and center frequency in women who participated
in three segregated experiments (Tables 1 and 2). Figs. 1 and 2
summarize center frequency and IAF of ongoing EEG in the
left and right parieto-occipital cortex. In each of the studies,
we identiﬁed the slowest center frequency in the late folli-
cular phase and the fastest in the luteal phase. Repeated
measures ANOVA, calculated for each study showed a sig-
niﬁcant difference between cycle phases for Po4 center
frequency in study 1 (F(2, 34)¼49.235, p¼ .000, η2¼ .743),
study 2 (F(2, 36)¼54.147, p¼ .000, η2¼ .751) and study 3 (F(2, 36)¼
73.849, p¼ .000, η2¼ .804). ANOVAs for Po3, P3 and P4 electro-
des revealed similar results. As expected, dependent
t-tests yielded that women showed signiﬁcant faster center
frequency in the luteal phase compared to late follicular
phase in study 1 (Po4 t(17)¼8.913, p¼ .000), study 2
(Po4 t(18)¼9.476, p¼ .000), and study 3 (Po4 t(18)¼10.450,
p¼ .000). Center frequency increased by 2–5% (by .1–.5 Hz)
from late follicular to luteal phase. Similarly, women showed
faster center frequency in the luteal phase compared to early
follicular phase in study 1(P3 t(17)¼12.866, p¼ .000), study 2
(P3 t(18)¼11.604, p¼ .000) and study 3 (Po4 t(18)¼8.663,
p¼ .000). Repeated measures ANOVA showed a signiﬁcant
difference between cycle phases for P3 IAF in study 2 (F(2, 36)¼
4.253, p¼ .037, η2¼ .191) but not in study 1 (F(2, 34)¼1.721,
p¼ .207, η2¼ .092) and study 3 (F(2, 36)¼ .557, p¼ .520, η2¼ .030).
ANOVAs for Po3, P3 and P4 electrodes revealed similar
results. Dependent t-tests showed that IAF was faster in
luteal compared to late follicular women in study 1 (P3
t(17)¼3.562, p¼ .002), study 2 (P3 t(18)¼2.241, p¼ .038), but
not in study 3. Center frequency revealed more signiﬁcant
associations than IAF (Figs. 1 and 2). However, we identiﬁed a
positive correlation between IAF and center frequency in all
three studies for women having a natural menstrual cycle as
well as for women using hormonal contraceptives (po.05).
For example, in early follicular women IAF (Po3) and center
Table 2 – Women using oral contraceptives (combination pill).
N Age range Mean
age7SD
Oral contraceptives Schedule of
studies
(modusa)
Study 1 17 19–26 22.5372.27 Desogestrel (n¼2), Gestoden (n¼2), Dienogest (n¼4),
Drospirenon (n¼8), Levonorgestrel (n¼1)
October to March (January)
Study 2 20 18–26 21.6072.19 Desogestrel (n¼1), Gestoden (n¼3), Dienogest (n¼3),
Drospirenon (n¼8), Levonorgestrel (n¼2), Cyproteron (n¼3)
November to March (January)
Study 3 20 20–28 2372.03 Desogestrel (n¼1), Gestoden(n¼2), Dienogest(n¼4),
Drospirenon(n¼8), Levonorgestrel(n¼3), Cyproteron(n¼1),
Chlormadinon(n¼1)
April to October (July)
Combined oral contraceptive pill contained ethinylestradiol (.015–.035 mg) and different doses of progestins. In study 1, two women were
excluded because they use different hormonal contraceptives then the classical combined contraceptive pill and other three because of
technical problems. In study 2, one subject was excluded because she did not ﬁnished the study. For correlational analyses between sex-
hormones and IAF one subject was excluded during pill intake and pill free week because her progesterone level was more than two standard
deviations higher than the mean. In study 3, one subject was excluded because she did not ﬁnished the study. One more participant was
excluded because she is a diabetic and need to regularly inject insulin. For correlational analyses between sex-hormones and IAF two
participants were excluded during pill free week because their progesterone level were more than two standard deviations higher than the
mean. Furthermore we had one missing values of progesterone level during pill intake phase because it was too high and therefore impossible
to measure.
a modus: month, in which most women were studied.
Table 1 – Women with a natural menstrual cycle.
N Age range Mean age7SD Mean cycle length Schedule of studies (modusa)
Study 1 18 16–33 24.0674.66 29.4471.9 September to March (December).
Study 2 19 19–30 23.3273.45 27.9772.32 December to April (February)
Study 3 20 19–29 24.8072.82 30.2372.47 April to October (October)
In study 1, we excluded two women because they had no menstruation since one year and two because of technical problems. For
correlational analyses between sex hormones and IAF, one subject was excluded in the late follicular and luteal phase because her estradiol
level was more than two standard deviations higher than the mean. In study 2, one subject was excluded because she did not ﬁnish the study.
For correlational analyses between sex hormones and IAF one subject was excluded in the early follicular and one subject in the late follicular
phase because their estradiol level was more than two standard deviations higher than the mean. Furthermore, one subject was excluded in
the late follicular and luteal phase and one subject in the luteal phase because their progesterone level was more than two standard
deviations higher than the mean. In study 3, one woman was excluded during luteal phase because of inadequate determination of luteal
phase. For correlational analyses between sex-hormones and IAF we excluded one participant in each cycle phase because her saliva sample
was contaminated with lipstick. One woman was excluded during late follicular and luteal phase because her progesterone level was more
than two standard deviations higher than the mean. Furthermore, we had one missing values of progesterone level during early follicular
phase because it was too high and, therefore, not quantiﬁable.
a modus: month, in which most women were studied.
b r a i n r e s e a r c h 1 5 7 7 ( 2 0 1 4 ) 3 6 – 4 438frequency (Po3) correlated positively in study 1 (r(16)¼ .672,
p¼ .002), in study 2 (r(17)¼ .705, p¼ .001), and study3 (r(17)¼ .714,
p¼ .001). Therefore, the reason why we got statistically
signiﬁcant results preferentially for center frequency com-
pared to IAF is due to the high variance in IAF.
2.2. IAF and center frequency are negatively correlated
with estradiol in women having a natural menstrual cycle
Because of the signiﬁcant association between IAF and center
frequency with menstrual cycle phase, we next correlated
estradiol and progesterone level with alpha frequency. In
general, we found that estradiol was negatively correlated
with IAF and with center frequency (Fig. 3).
IAF correlated negatively with estradiol in luteal phase in
study 1 (P4 r(15)¼ .415, p¼ .098) and study 2 (P4 r(15)¼ .483,
p¼ .049) as well as in late follicular phase in study 1(P3 r(15)¼ .468, p¼ .058) and study 3 (P4 r(16)¼ .608,
p¼ .007). Similarly, center frequency correlated negatively
with estradiol in luteal phase in study 1 (P4 r(15)¼ .683,
p¼ .003), in late follicular phase in study 1 (P4 r(15)¼583,
p¼ .014) and study 3 (P4 r(16)¼ .501, p¼ .034), as well as in
early follicular phase in study 1 (P4 r(16)¼503, p¼ .033). In
parietal and parieto-occipital electrodes, the signiﬁcance of
negative correlations between estradiol level and center
frequency varied between p¼ .003 and p¼ .098. In contrast to
estradiol, we did not detect signiﬁcant correlations (po.05)
between progesterone and IAF or center frequency.
2.3. Oral contraceptives and alpha oscillations
In oral contraceptive users in the active phase, Po3 center
frequency ranges between 9.64 and 11.12 Hz with an average
of 10.277.37 (n¼57), and in the inactive phase between 9.33
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Fig. 1 – Average alpha center frequency (M7SD) in women with a natural menstrual cycle and women using oral
contraceptives. Late follicular women show lowest center frequency. EFP: early follicular phase, LFP: late follicular phase,
LP: luteal phase; pill intake phase: active phase, pill free week: inactive phase; *po.05; **po.01.
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Fig. 2 – Average IAF (M7SD) in women with a natural menstrual cycle and women using oral contraceptives. Late follicular
women reveal lowest IAF. EFP: early follicular phase, LFP: late follicular phase, LP: luteal phase; pill intake phase: active
phase, pill free week: inactive phase; *po.05; **po.01.
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Fig. 3 – Estradiol level correlates negatively with alpha frequency. (A) The regression line shows a negative correlation
between estradiol and center frequency in luteal woman. (B) Alpha oscillation (ﬁltered between 7 and 14 Hz) from late
follicular women having either a low estradiol or high estradiol level.
b r a i n r e s e a r c h 1 5 7 7 ( 2 0 1 4 ) 3 6 – 4 440and 10.85 Hz with an average of 10.057.31 (n¼57). In general,
center frequency, but not IAF, revealed a signiﬁcant faster
frequency in the active compared to inactive phase of oral
contraceptive use (Fig. 1) in study 1 (P3 t(17)¼8.961, p¼ .000),
study 2 (P3 t(19)¼4.217, p¼ .000), and study 3 (P3 t(19)¼11.315,
p¼ .000). Thus, the impact of oral contraceptives on alpha
frequency was reversible within a few days.
In study 2 and 3, the center frequency recorded from
parieto-occipital cortex was smaller in women using
oral contraceptives (active phase) than in women in the
luteal phase (study 2: Po3 t(33)¼6.608, p¼ .000; study 3: Po4
t(37)¼4.522, p¼ .000), but faster than in late follicular women
in study 2 (P3 t(37)¼4.491, p¼ .000). In study 1, women using
oral contraceptives (active phase) had a higher center
frequency compared to women in the luteal phase
(P4 t(33)¼8.850, p¼ .000). However, in this study, women
having a natural menstrual cycle revealed slower center
frequency or IAF compared to women in study 2 and study 3
(Figs. 1 and 2). Whether differences in alpha frequencies are
related to external factors, like seasonal differences (Tables 1
and 2), remains to be evaluated. Comparison of oral
contraceptive-free interval revealed similar results. When we
used IAF, we identiﬁed a higher IAF during active phase
compared to luteal phase in study 1 (P3 t(33)¼2.187,
p¼ .036), but a lower IAF during inactive phase compared to
luteal phase in study 3 (Po4 t(37)¼2.281, p¼ .028).
Women using hormonal contraceptives (active phase) are
characterized by signiﬁcantly lower estradiol concentration
than normally cycling women during late follicular phase
(t(32)¼1.991, p¼ .055) and luteal phase (t(32)¼2.062, p¼ .047) in
study 1, during early follicular (t(35)¼2.058, p¼ .047), late
follicular (t(34)¼4.912, p¼ .000) and luteal phase (t(34)¼3.094,
p¼ .004) in study 2. In contrast to women having a natural
menstrual cycle, women using oral contraceptives did not
reveal an association between estradiol and alpha frequency
(p4.05) in active and inactive phase.3. Discussion
Our conﬁrmation of previous EEG ﬁndings (Becker et al., 1982,
Creutzfeldt et al., 1976) in three independent studies demon-
strates a robust effect of menstrual cycle on alpha frequency.
In addition, we identiﬁed a negative correlation between
estradiol and frequency of the alpha band. This provides a
further hint of the interplay between neural activity and
endocrine system. Furthermore, similar to the results of
Becker and colleagues (Becker et al., 1982), we ﬁnd that
women using oral contraceptives have an alpha frequency
close to early follicular women.
The brain is not a reﬂexive organ, but intrinsically active.
Raichle and colleagues deﬁned a default mode by comparing
deviations in the local oxygen extraction fraction with mean
hemisphere oxygen extraction fraction (Raichle et al., 2001).
These authors identiﬁed brain areas tonically active in a
baseline state along midline areas, including precuneus,
posterior cingulate, and medial prefrontal cortex, as well as
in some lateral areas, speciﬁcally in parietal cortex. A default
system, which is task-independently active, has since then
been identiﬁed in numerous fMRI and PET studies (Raichle,
2010). The earliest electrophysiological documentation of
intrinsic brain activity dates back to 1929, when Hans Berger
published ongoing alpha activity in awake but resting indivi-
duals with eyes closed (Berger, 1929). We as well as Creutz-
feldt and colleagues (Becker et al., 1982, Creutzfeldt et al.,
1976) demonstrate reliable cyclic changes in alpha frequen-
cies in women. Since resting alpha frequency is a predictor
for cognitive performance (Grandy et al. 2013), menstrual
cycle-dependent changes in alpha activity may have func-
tional consequences in performance.
Elevated estradiol correlates with a higher spine density in
hippocampal pyramidal neurons in rodents and non-human
primates and an increased synaptic excitatory potential in
rodents (McEwen, 2010, McEwen et al., 2012). Surprisingly, we
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frequency. This may indicate that these neuroanatomical and
physiological ﬁndings are more related to EEG amplitudes
rather than frequency or to different frequency bands com-
pared to alpha band. Interestingly, an association between
low estradiol and fast alpha frequency was also detectable in
our study in two participants where menstruation failed to
occur at least in the last twelve months. In general, these
women had high IAF. One woman showed on both EEG
sessions a high IAF of 11.48 Hz and 12.45 Hz, and the second
an IAF of 10.99 and 8.06 Hz, respectively. Changes in alpha
frequency during the menstrual cycle may be related to the
modulatory impact of estradiol and progesterone on synaptic
transmission. Noticeably, alpha frequency is lower in late
follicular phase compared to early follicular phase or luteal
phase. Early follicular phase and luteal phase have in com-
mon that levels of estradiol or progesterone are either low
(early follicular phase) or high (luteal phase), but the ratio of
estradiol to progesterone is similar. In the late follicular
phase, the level of estradiol is elevated, but the level of
progesterone is low. Thus, the ratio of estradiol to progester-
one is high in the late follicular phase. Cyclic changes in sex
steroids are paralleled by changes in gene expression in the
nervous system. Interestingly, estradiol modulates expres-
sion of GABA A receptors as well as glutamate decarboxylase.
GABA A receptors are upregulated in proestrus rats, where
estradiol is elevated (Puri et al., 2011). Furthermore, the gad2
promotor, required for expression of glutamate decarboxy-
lase, is a target of estradiol receptors (Hudgens et al., 2009).
GABAergic synaptic transmission is modulated by progester-
one and its metabolites. Accordingly, estradiol-dependent
expression of GABA A receptors and the GABA synthesizing
enzyme, glutamate decarboxylase, may affect alpha fre-
quency. The modulation of GABAergic transmission may be
different when the ratio of estradiol to progesterone is
similar, like in early follicular phase and luteal phase, or
when the ratio is high, like in the late follicular phase.
Changes in frequency of ongoing alpha oscillations (Becker
et al., 1982, present study) and food intake (Lyons et al., 1989,
Buffenstein et al., 1995) across the menstrual cycle are in
parallel. These studies demonstrate a decrease in food intake
during the periovulatory, but an increase in the luteal phase.
Our study reveals a decrease in alpha frequency in the late
follicular phase compared to the luteal phase. We suggest
that this similarity is beyond chance. The human brain
weighs 2% of the total body weight, but consumes 20% of
the bodies resting energy budget (Raichle, 2010). More than
90% of cortical synapses are glutamatergic (Braitenberg,
Schüz, 1991). In the human brain, glutamatergic synapses
are the dominant ATP consumers with an estimated 60% to
80% of the energy used by intrinsic brain activity (Attwell and
Laughlin, 2001, Raichle, 2010). Accordingly, increase in gluta-
matergic activity predicts accelerated ATP consumption. If
an increase in estradiol is coupled to a decrease in food
consumption, a decline in alpha frequency saves energy
because synapses are activated less frequently. Interestingly,
although estradiol to progesterone ratio changes between
late follicular phase and luteal phase, estradiol does not vary
that much between these menstrual cycle phases. Individuals
low in estradiol have higher IAF and center frequencycompared to women high in estradiol. Accordingly, these
individuals should differ in metabolism. In preliminary
results, we found in the luteal phase a positive correlation
between body temperature and center frequency (r(19)¼ .451,
p¼ .053). Although many women taking a combination pill
complain about weight gain as an adverse side effect, meta-
studies on this topic did not ﬁnd empirical evidence (Gupta,
2000, Lindh et al., 2011). Nevertheless, correlative studies
between brain and body metabolism in women using oral
contraceptives would be of interest to identify the impact of
ethinyl estradiol, a synthetic steroid in hormonal contra-
ceptives, on neural activity.
Structure and activity of the brain of women using oral
contraceptives differ from those women having a natural
menstrual cycle (Pletzer et al., 2010, De Bondt et al., 2013,
Pletzer et al., 2014). Critically, differences between oral con-
traceptive users and non-users are detectable under resting
state conditions of the brain. Petersen and colleagues
describe a decrease in connectivity in oral contraceptive users
and luteal women, suggesting the synthetic hormones in oral
contraceptives and endogenous sex hormones have a similar
effect on connectivity in the resting state (Petersen et al.,
2014). In the present study, we ﬁnd a similar alpha frequency
in oral contraceptive users and early follicular women. If
ethinyl estradiol substitute endogenous, consumption of oral
contraceptives predict a decrease in center frequency or IAF.
Similarity in alpha frequency in oral contraceptive users and
early follicular women indicate that either ethinyl estradiol is
not as efﬁcient as endogenous estradiol in decreasing alpha
frequency or combination of ethinyl estradiol and progestins
have an enhancing effect on alpha frequency.
In conclusion, our study demonstrates that menstrual
cycle phase and, speciﬁcally, estradiol correlates with alpha
frequency. Given the importance of menstrual cycle and sex-
hormone associated differences in cognitive tasks (Hampson
and Kimura, 1992; Phillips and Sherwin, 1992, Hampson, 1990,
Hausmann et al., 2000, Rosenberg and Park, 2002, Maki et al.,
2002) and the predictor capacity of alpha frequency on task
performances (Grandy et al., 2013), modulation of ongoing
oscillations by estradiol may be a link between performance
and sex hormone changes.4. Experimental procedures
4.1. Participants
EEG recordings were collected from three subject groups (see
Tables 1 and 2). Most women were recruited from the
University of Salzburg (Department of Biology, Department
of Psychology) and gave their written informed consent.
Participants were free of medication and reported no history
of neurological disorders. Our studies were approved by the
local ethics committee.
4.2. Salivary sex hormone analysis
Estradiol and progesterone were quantiﬁed using Demetitec
Salivary Estradiol ELISA kids according to the recommenda-
tions of the provider. Each participant provided a saliva
b r a i n r e s e a r c h 1 5 7 7 ( 2 0 1 4 ) 3 6 – 4 442sample before an EEG-session. Saliva samples were collected
in sterile centrifuge tubes, stored in a freezer at 20 1C.
Particles in saliva samples were removed by centrifugation
(2355 g for 15 min) before sex hormone quantiﬁcation.
Tables 3 and 4 summarize mean and standard deviation of
estradiol and progesterone levels.4.3. EEG recordings
EEG signals were recorded while women sat in an armchair in
a sound-attenuated room with eyes closed for ﬁve minutes.
Women having a natural menstrual cycle were tested in early
(onset of menstruation plus ﬁve days) and late follicular
phase (approximately 14 days before onset of menstruation)
as well as in luteal phase (three days post ovulation to ﬁve
days before the onset of menstruation). Late follicular phase
was estimated by verbal reports and by use of a commercial
ovulation tests (PregnaﬁxsOvulationstest). About a third of
the participants started in early follicular phase, late follicular
phase, and luteal phase, respectively. With six exceptions,
the three EEG sessions were a maximum of one menstrual
cycle apart. Women using hormonal contraceptives were
tested twice, once during administration pause (inactive
phase) and once during intake of the pill (active phase).
About one half of the participants started in the active and
the second half in the inactive phase.4.4. Acquisition of EEG data
32 Ag–AgCl electrodes were used in study 1 and 64 Ag–AgCl
electrodes were used in study 2 and study 3, respectively, to
record EEG signals. Electrodes were referenced to a nose
electrode and a grounding electrode was located on the
forehead. Electrode positions were according to the 10–20
system (Jaspers, 1958). Signals were ampliﬁed with a Brai-
nAmp ampliﬁer (Brain Products, Inc., Gilching, Germany)
using a sampling rate at 1000 Hz. To eliminate 50 Hz
oscillation, a notch ﬁlter at 50 Hz was applied and recording
bandwidth was set from .016 to 100 Hz. Eye movements wereTable 3 – Mean7SD for estradiol- (E2) and progesterone-level (
phase (LFP) and luteal phase (LP).
EFP LFP
E2 P E2
Study 1 n (18) 3.9471.82 n (18) 62.34757.74 n (17) 4.4372.07
Study 2 n (18) 5.4272.05 n (18) 131.157101.35 n (17) 7.5072.43
Study 3 n (19) 8.4674.13 n (18) 87.74754.72 n (18) 9.8173.91
Table 4 – Mean7SD for estradiol- (E2) and progesterone-level (
Pill intake phase
E2 P
Study 1 n (17) 3.0971.84 n (17) 171.617138.
Study 2 n (19) 4.1971.56 n (19) 77.66754.5
Study 3 n (20) 10.9174.60 n (19) 123.16780.4controlled by two electrodes set at vertical and horizontal
positions near the right eye. Impedance was kept below 8 kΩ.4.4.1. Data-analysis
EEG data were analyzed using BrainVisionAnalyzer 2.0 (Brain
Products, Inc., Gilching, Germany). Raw EEG data were re-
referenced to earlobe-electrodes and ﬁltered with an IIR
bandpass ﬁlter between .5 and 40 Hz in study 1 or .5 and
70 Hz in study 2 and study 3, respectively. Eye artifacts (EOG)
were removed using ocular correction based on Gratton and
Coles (Gratton et al., 1983). Remaining artifacts were elimi-
nated by skipping bad intervals following visual inspection.4.4.2. Individual alpha frequency and gravity frequency
Alpha frequency is characterized either as peak or gravity
frequency within the traditional alpha frequency band of
about 8–12 Hz. Peak frequency was estimated as the spectral
component within f1 to f2 which showed the largest power.
To calculate the individual alpha frequency (IAF) and the
center frequency, respectively, we segmented ﬁve minutes
resting-conditions eyes closed into consecutive 4000 ms seg-
ments and applied a Fast-Fourier-Transformation (FFT) with
a .24 Hz resolution using the Hanning window (10%). After
averaging, we inspected visually the highest peak of the Po3,
Po4, P3 and P4 electrodes within a frequency window from 7
to 14 Hz and noted the peak frequency (IAF). We choose a
similar frequency window as Becker et al. (1982) used. Center
or gravity frequency is the weighted sum of spectral esti-
mates, divided by alpha power (∑(a(f) f))/(∑a(f))a(f) is
power spectral estimate at frequency f. Summation ranges
from f1 to f2. Gravity or center frequency is more appropriate
when multiple peaks are detected in the alpha range
(Klimesch, 1999). We calculated the center frequency using
MATLAB (R2010b). The frequency window f1 to f2 was deﬁned
collectively for each cycle phase or pill intake phase and pill
free week as the mean IAF72 Hz. For example if the mean
IAF during early follicular phase is 10.06 Hz than f1 is 8.06 Hz
and f2 is 12.06 Hz.P) (in pg/ml) for early follicular phase (EFP) late follicular
LP
P E2 P
n (17) 64.76 732.21 n (17) 4.2671.42 n (17) 134.677105.94
n (17) 193.04787.61 n (17) 6.74 73.20 n (17) 334.437104.38
n (18) 95.19781.66 n (17) 9.0273.90 n (17) 290.797177.45
P) (in pg/ml) for pill intake phase and pill free week.
Pill free week
E2 P
66 n (17) 3.8672.18 n (17) 137.35762.93
7 n (19) 4.4971.55 n (19) 71.45733.37
9 n (18) 10.0174.08 n (18) 85.23753.57
b r a i n r e s e a r c h 1 5 7 7 ( 2 0 1 4 ) 3 6 – 4 4 434.5. Statistical methods
PASW Statistics 18 (SPSS) was used for statistical analysis. To
test for cycle-dependent differences in center frequency or
IAF, a repeated measure ANOVA with the factor IAF or center
frequency was calculated separately for each electrode.
Dependent t-tests showed differences in center frequency
or IAF between individual cycle phases and independent
t-tests showed differences between naturally cycling women
and women using oral contraceptives. Estradiol levels were
associated with center frequency or IAF using the Pearson
correlation coefﬁcient (2-tailed).Acknowledgments
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